The Need For Speed In Life Sciences

Regulation has long been the go‑to justification for slow digital progress in life sciences, but today the pace of technology is outstripping the pace of guidance. Organizations can no longer afford to wait. This conversation dives into why speed has become such a defining challenge for pharma and medical device manufacturers, and why old assumptions about validation and risk are holding teams back. Michelle Vuolo and Gilad Langer unpack the realities of Validation 4.0, the cultural hesitation around truly risk‑based thinking, and the ways AI is already reshaping quality and compliance work. For leaders navigating increasing complexity and regulatory uncertainty, take a look at how to move faster without losing control.